Hello readers, as always we hope your weekend was fantastic. For some of us stock addicts, the weekend stinks because the market is closed, but offers a great time to research companies. On that note, lets recap and share my thoughts about this past week’s mentioned companies on PSInvestor.com.
$OMVS…What will this week bring? Merger finalized… Contracts… Maybe Microsoft related news? Definitely an exciting time to be in the stock. Friday closed at 0.252 +0.049 (+24.14%). How high will she go? That all depends on how large future contracts are and the ability to attract wallstreet type investors. I personally would like to see an uplist to the QB from the pinksheets along with a name and CUSIP number change. RAD CEO Steve Reinharz has already confirmed that Garret Parsons will remain CEO after the merger via a tweet recently.
$PLSB…Closed Friday at 0.0047 +0.0024 (+104.35%) on the day. Pulse Beverage was at a low of .0012 on 8/1/17 and has rise over 400% from that point. A recent press release regarding the Fiesta Mart of Texas acquisition ultimately set the stock on fire.
$MLFB…We just released an “exclusive interview” with their new CEO Jerry C Craig. MLFB is in “REBOOT” mode, as the new CEO is ready for the challenge of getting this developmental league turned around. Share price is UP 300% off its 52 week low last month of $0.06 a share. A new company site is set to launch later this month. $MLFB is the ONLY publicly traded sports league.
$OXIS…Had a very strong week nearly doubling in price as investors position themselves prior to the merger acquisition of GT Pharma. GT Pharma’s CEO Prior to founding GTP, Dr. Clarence-Smith co-founded Chase Pharmaceuticals Corporation in Washington D.C. and served as Chairman of the company’s Board from 2008 to 2014. Chase Pharmaceuticals was acquired by Allergan, PLC (AGN) in 2016 in a deal that, with milestones, could reach $1 billion. $OXIS is giving up 33% of their stock for this acquisition which will close by September 30th. Dr. Clarence-Smith will become the new CEO of OXIS and additionally, a Chief Medical Officer, who formerly served as CMO with Pfizer, will join OXIS under the deal. That’s a pretty solid leadership team for a biotech that has a market cap of only $5.78 million. OXIS closed at .04 Friday.
$PHIL…hit a week low of 0.023 on 8/1/17, yet hit an inter-day high of 0.1942 (800% rise off the low). PHIL closed Friday at 0.145 down 1%. As you can see, the company has been able to hold its solid gains. According to a DD post on iHub, this is the reason for PHIL’s recent run…
- 1) Acquisition of Maxagro Farm SRL to close by August 8th https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12104566,
- 2) CEO buys 20M shares form 4 filed on 7/27 https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12194034,
- 3) paid off debenture on July 24, 2017, the Company paid a total of $49,530.72 to Auctus Fund LLC
- 4) low float no toxic financing
- 5) another acquisition Constructii SA, coming https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12154622
$STBV…We saw a wild week, as it was a mere penny that ran to 0.14 on PR’s of cryptocurrency assets and dividends only to be halted by the SEC. Their CEO, Garland E. Harris was quick to respond later in the day that not only is the proper paperwork being filed, but hinted at a future forward split of the stock. The company is set to resume trading August 18th, 2017. Long investors, whom are stuck, are praying the CEO does the right thing to get the company back on track. We will follow up on this one later in the month.
NEWSLETTER PROMOS
(none so far…will update as the night progresses)